The board of directors of CANbridge Pharmaceuticals Inc. announced that the principal place of business of the Company in Hong Kong will be changed to Room B01, 20/F, CITIC Tower, 1 Tim Mei Avenue, Admiralty, Hong Kong with effect from April 15, 2024. The website of the Company remain unchanged.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 HKD | 0.00% | 0.00% | -65.66% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.66% | 18.49M | |
+18.88% | 80.5B | |
+14.11% | 9.15B | |
-14.14% | 4.9B | |
+43.39% | 4.49B | |
+18.90% | 4.44B | |
+7.93% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- 1228 Stock
- News CANbridge Pharmaceuticals Inc.
- CANbridge Pharmaceuticals Inc. Announces Change of Principal Place of Business in Hong Kong, Effect from April 15, 2024